Facebook Twitter LinkedIn Google Plus RSS

Princeton-based drug researcher opens Tokyo office

By ,

WIRB-Copernicus Group, a Princeton-based medical research group, has opened a Tokyo office to expand its capabilities in conducting global clinical trials.

The company’s Tokyo office will have a particular focus conducting trials for drug and diagnostic development for oncology and central nervous system diseases. WCG said the opening of the office helps alleviate some of the difficulties in rounding up appropriate sub populations for clinical trials.

In the past decade, Asia has become an increasingly attractive destination for clinical research, with a clinical trials infrastructure designed to foster speed, cost effectiveness and quality. 

You May Have Missed...

Vince Calio

Vince Calio


Vince Calio covers health care and manufacturing for NJBIZ. You can contact him at vcalio@njbiz.com.

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close